241 related articles for article (PubMed ID: 34053427)
1. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
2. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
[TBL] [Abstract][Full Text] [Related]
3. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
5. RAD001 can reverse drug resistance of SGC7901/DDP cells.
Ying L; Zu-An Z; Qing-Hua L; Qing-Yan K; Lei L; Tao C; Yong-Ping W
Tumour Biol; 2014 Sep; 35(9):9171-7. PubMed ID: 24920069
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Liu M; Yang Y; Liu D; Cao Y; Li Y
J Tradit Chin Med; 2020 Dec; 40(6):908-916. PubMed ID: 33258341
[TBL] [Abstract][Full Text] [Related]
8. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
[TBL] [Abstract][Full Text] [Related]
9. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
10. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
[TBL] [Abstract][Full Text] [Related]
11. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms.
Zhu ZA; Zhu ZQ; Cai HX; Liu Y
Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836
[TBL] [Abstract][Full Text] [Related]
12. Reversing effect of NOTCH1 inhibitor LY3039478 on drug-resistance cells SGC7901/DDP of human gastric cancer and its mechanism.
Wang YL; Zhang Y; Huang XY; Zheng Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4121-4127. PubMed ID: 30024600
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
14. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
15. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
Zhu QL; Li Z; Lv CM; Wang W
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901.
Xie XQ; Zhao QH; Wang H; Gu KS
World J Gastroenterol; 2017 Feb; 23(7):1189-1202. PubMed ID: 28275299
[TBL] [Abstract][Full Text] [Related]
18. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
[TBL] [Abstract][Full Text] [Related]
19. RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo.
Zhou W; Fu XQ; Liu J; Yu HG
Regul Pept; 2012 Jun; 176(1-3):13-21. PubMed ID: 22387880
[TBL] [Abstract][Full Text] [Related]
20. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
